Reference SummaryDeng Q, Nat Commun 2019 Nov 7;10(1):5061
Title |
Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant. | ||||||||||||||
Authors |
Deng Q; Hu H; Yu X; Liu S; Wang L; Chen W; Zhang C; Zeng Z; Cao Y; Xu-Monette ZY; Li L; Zhang M; Rosenfeld S; Bao S; Hsi E; Young KH; Lu Z; Li Y | ||||||||||||||
Journal |
Nat Commun | ||||||||||||||
Volume |
10 | ||||||||||||||
Issue |
1 | ||||||||||||||
Year |
2019 | ||||||||||||||
Pages |
5061 | ||||||||||||||
Abstract |
A noncoding polymorphism (rs78378222) in TP53, carried by scores of millions of people, was previously associated with moderate risk of brain tumors and other neoplasms. We find a positive association between this variant and soft tissue sarcoma. In sharp contrast, it is protective against breast cancer. We generated a mouse line carrying this variant and found that it accelerates spontaneous tumorigenesis and glioma development, but strikingly, delays mammary tumorigenesis. The variant creates a miR-382-5p targeting site and compromises a miR-325-3p site. Their differential expression results in p53 downregulation in the brain, but p53 upregulation in the mammary gland of polymorphic mice compared to that of wild-type littermates. Thus, this variant is at odds with Li-Fraumeni Syndrome mutants in breast cancer predisposition yet consistent in glioma predisposition. Our findings elucidate an underlying mechanism of cancer susceptibility that is conferred by genetic variation and yet altered by microRNA expression. | ||||||||||||||
Links |
J:281362 – MGI References 31699989 – National Library of Medicine/PubMed |
||||||||||||||
Strain Notes
|
Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
---|---|---|---|---|---|
C57BL/6 | CNS - Brain glioma |
|
CNS - Brain |
0 |
|
C57BL/6-Trp53em1Yoli/+ | CNS - Brain glioma |
|
CNS - Brain |
0 |
|
C57BL/6-Trp53em1Yoli | CNS - Brain glioma |
|
CNS - Brain |
100 |
|
B6.129S2-Trp53tm1Tyj/J | CNS - Brain glioma |
|
CNS - Brain |
100 |
|
B6.129S2-Trp53tm1Tyj/J | CNS - Brain glioma |
|
CNS - Brain |
100 |
|
C57BL/6 | Intestine - Small Intestine carcinoma | Intestine - Small Intestine |
0 |
||
C57BL/6-Trp53em1Yoli/+ | Intestine - Small Intestine carcinoma | Intestine - Small Intestine |
observed |
||
C57BL/6-Trp53em1Yoli | Intestine - Small Intestine carcinoma | Intestine - Small Intestine |
observed |
||
C57BL/6-Trp53em1Yoli/+ | Leukocyte - Lymphocyte - B-lymphocyte - Follicular center cell lymphoma - follicular | Leukocyte - Lymphocyte - B-lymphocyte - Follicular center cell |
37 |
||
C57BL/6-Trp53em1Yoli | Leukocyte - Lymphocyte - B-lymphocyte - Follicular center cell lymphoma - follicular | Leukocyte - Lymphocyte - B-lymphocyte - Follicular center cell |
31 |
||
C57BL/6-Trp53em1Yoli/+ | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell plasmacytoma | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell |
5.7 |
||
C57BL/6-Trp53em1Yoli | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell plasmacytoma | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell |
2.8 |
||
C57BL/6-Trp53em1Yoli/+ | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell plasmacytoma - malignant | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell |
0 |
||
C57BL/6-Trp53em1Yoli | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell plasmacytoma - malignant | Leukocyte - Lymphocyte - B-lymphocyte - Plasma cell |
2.8 |
||
C57BL/6 | Leukocyte - Lymphocyte - B-lymphocyte lymphoma |
|
Leukocyte - Lymphocyte - B-lymphocyte |
observed |
|
C57BL/6-Trp53em1Yoli/+ | Leukocyte - Lymphocyte - B-lymphocyte lymphoma |
|
Leukocyte - Lymphocyte - B-lymphocyte |
observed |
|
C57BL/6-Trp53em1Yoli | Leukocyte - Lymphocyte - B-lymphocyte lymphoma |
|
Leukocyte - Lymphocyte - B-lymphocyte |
observed |
|
C57BL/6-Trp53em1Yoli/+ | Leukocyte - Lymphocyte - B-lymphocyte lymphoma - diffuse large cell (DLCL) | Leukocyte - Lymphocyte - B-lymphocyte |
20 |
||
C57BL/6-Trp53em1Yoli | Leukocyte - Lymphocyte - B-lymphocyte lymphoma - diffuse large cell (DLCL) | Leukocyte - Lymphocyte - B-lymphocyte |
17 |
||
C57BL/6-Trp53em1Yoli/+ | Leukocyte - Lymphocyte - B-lymphocyte lymphoma - splenic marginal zone | Leukocyte - Lymphocyte - B-lymphocyte |
5.7 |
||
C57BL/6-Trp53em1Yoli | Leukocyte - Lymphocyte - B-lymphocyte lymphoma - splenic marginal zone | Leukocyte - Lymphocyte - B-lymphocyte |
14 |
||
C57BL/6-Trp53em1Yoli/+ | Leukocyte - Lymphocyte - B-lymphocyte tumor - malignant | Leukocyte - Lymphocyte - B-lymphocyte |
69 |
||
C57BL/6-Trp53em1Yoli | Leukocyte - Lymphocyte - B-lymphocyte tumor - malignant | Leukocyte - Lymphocyte - B-lymphocyte |
67 |
||
C57BL/6 | Leukocyte - Lymphocyte - T-lymphocyte lymphoma |
|
Leukocyte - Lymphocyte - T-lymphocyte |
observed |
|
C57BL/6-Trp53em1Yoli/+ | Leukocyte - Lymphocyte - T-lymphocyte lymphoma |
|
Leukocyte - Lymphocyte - T-lymphocyte |
observed |
|
C57BL/6-Trp53em1Yoli/+ | Leukocyte - Lymphocyte - T-lymphocyte lymphoma | Thymus |
0 |
||
C57BL/6-Trp53em1Yoli | Leukocyte - Lymphocyte - T-lymphocyte lymphoma |
|
Leukocyte - Lymphocyte - T-lymphocyte |
observed |
|
C57BL/6-Trp53em1Yoli | Leukocyte - Lymphocyte - T-lymphocyte lymphoma | Thymus |
0 |
||
C57BL/6 | Leukocyte lymphoma | Leukocyte |
6 |
||
C57BL/6 | Leukocyte lymphoma |
|
Leukocyte |
60 |
|
C57BL/6-Trp53em1Yoli/+ | Leukocyte lymphoma | Leukocyte |
observed |
||
C57BL/6-Trp53em1Yoli/+ | Leukocyte lymphoma |
|
Leukocyte |
observed |
|
C57BL/6-Trp53em1Yoli | Leukocyte lymphoma | Leukocyte |
observed |
||
C57BL/6-Trp53em1Yoli | Leukocyte lymphoma |
|
Leukocyte |
observed |
|
B6FVBF1-Tg(MMTVneu)202Mul Trp53em1Yoli/+ | Leukocyte lymphoma | Leukocyte |
9.5 |
||
B6FVBF1-Tg(MMTVneu)202Mul Trp53tm1Tyj/+ | Leukocyte lymphoma | Leukocyte |
33 |
||
C57BL/6 | Lung adenocarcinoma | Lung |
0 |
||
C57BL/6-Trp53em1Yoli/+ | Lung adenocarcinoma | Lung |
0 |
||
C57BL/6-Trp53em1Yoli | Lung adenocarcinoma | Lung |
observed |
||
B6FVBF1-Tg(MMTV-PyVT)634Mul | Mammary gland neoplasia | Mammary gland |
observed |
||
B6FVBF1-Tg(MMTV-PyVT)634Mul Trp53em1Yoli/+ | Mammary gland neoplasia | Mammary gland |
observed |
||
B6FVBF1-Tg(MMTVneu)202Mul Trp53em1Yoli/+ | Mammary gland neoplasia |
|
Mammary gland |
observed |
|
B6FVBF1-Tg(MMTV-PyVT)634Mul | Mammary gland tumor | Mammary gland |
100 |
||
B6FVBF1-Tg(MMTV-PyVT)634Mul Trp53em1Yoli/+ | Mammary gland tumor | Mammary gland |
100 |
||
B6;FVB-Tg(MMTV-PyVT)634Mul | Mammary gland tumor | Mammary gland |
100 |
||
B6;FVB-Tg(MMTV-PyVT)634Mul Trp53em1Yoli/+ | Mammary gland tumor | Mammary gland |
100 |
||
B6;FVB-Tg(MMTV-PyVT)634Mul Trp53em1Yoli | Mammary gland tumor | Mammary gland |
100 |
||
B6FVBF1-Tg(MMTVneu)202Mul | Mammary gland tumor | Mammary gland |
33 |
||
B6FVBF1-Tg(MMTVneu)202Mul | Mammary gland tumor |
|
Mammary gland |
0 |
|
B6FVBF1-Tg(MMTVneu)202Mul | Mammary gland tumor |
|
Mammary gland |
29 |
|
B6FVBF1-Tg(MMTVneu)202Mul Trp53em1Yoli/+ | Mammary gland tumor | Mammary gland |
24 |
||
B6FVBF1-Tg(MMTVneu)202Mul Trp53em1Yoli/+ | Mammary gland tumor |
|
Mammary gland |
0 |
|
B6FVBF1-Tg(MMTVneu)202Mul Trp53em1Yoli/+ | Mammary gland tumor |
|
Mammary gland |
88 |
|
B6FVBF1-Tg(MMTVneu)202Mul Trp53tm1Tyj/+ | Mammary gland tumor | Mammary gland |
40 |
||
C57BL/6 | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
0 |
||
C57BL/6 | Mesodermal cell/mesoblast sarcoma |
|
Mesodermal cell/mesoblast |
0 |
|
C57BL/6-Trp53em1Yoli/+ | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
observed |
||
C57BL/6-Trp53em1Yoli/+ | Mesodermal cell/mesoblast sarcoma |
|
Mesodermal cell/mesoblast |
observed |
|
C57BL/6-Trp53em1Yoli | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
observed |
||
C57BL/6-Trp53em1Yoli | Mesodermal cell/mesoblast sarcoma |
|
Mesodermal cell/mesoblast |
0 |
|
C57BL/6 | Ovary tumor - malignant |
|
Ovary |
0 |
|
C57BL/6-Trp53em1Yoli/+ | Ovary tumor - malignant |
|
Ovary |
0 |
|
C57BL/6-Trp53em1Yoli | Ovary tumor - malignant |
|
Ovary |
observed |
|
C57BL/6 | (Unspecified organ) tumor | (Unspecified organ) |
6 |
||
C57BL/6 | (Unspecified organ) tumor |
|
(Unspecified organ) |
60 |
|
C57BL/6-Trp53em1Yoli/+ | (Unspecified organ) tumor | (Unspecified organ) |
47 |
||
C57BL/6-Trp53em1Yoli/+ | (Unspecified organ) tumor |
|
(Unspecified organ) |
88 |
|
C57BL/6-Trp53em1Yoli | (Unspecified organ) tumor | (Unspecified organ) |
67 |
||
C57BL/6-Trp53em1Yoli | (Unspecified organ) tumor |
|
(Unspecified organ) |
92 |
|
B6FVBF1-Tg(MMTVneu)202Mul Trp53em1Yoli/+ | (Unspecified organ) tumor | (Unspecified organ) |
33 |
||
B6FVBF1-Tg(MMTVneu)202Mul Trp53tm1Tyj/+ | (Unspecified organ) tumor | (Unspecified organ) |
60 |